Lataa...
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
Acinetobacter baumannii is currently classified as one of six pathogens that contribute to increased patient mortality. Thus, exploratory studies navigating alternative treatment strategies are of supreme interest. Herein, we completed minimum inhibitory concentration (MIC) testing, and time-kill an...
Tallennettuna:
| Julkaisussa: | Antibiotics (Basel) |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8300792/ https://ncbi.nlm.nih.gov/pubmed/34356801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10070880 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|